KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 151 filers reported holding KITE PHARMA INC in Q1 2015. The put-call ratio across all filers is 1.21 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $726,000 | +227.0% | 4,039 | -18.2% | 0.06% | +150.0% |
| Q4 2016 | $222,000 | +276.3% | 4,938 | +419.8% | 0.02% | +140.0% |
| Q4 2015 | $59,000 | -30.6% | 950 | -38.4% | 0.01% | +25.0% |
| Q3 2015 | $85,000 | +14.9% | 1,542 | +26.3% | 0.01% | +14.3% |
| Q2 2015 | $74,000 | +111.4% | 1,221 | +103.2% | 0.01% | +75.0% |
| Q1 2015 | $35,000 | +400.0% | 601 | +141.4% | 0.00% | +300.0% |
| Q3 2014 | $7,000 | – | 249 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|